登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码：603696 证券简称：安记食品 公告编号：2025-014 安记食品股份有限公司 2024年度与行业相关的定期经营数据公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性承担个别及连带责任。 单位：万元 币种：人民币 ■ 二、报告期经销商情况 单位：个 ■ 特此公告。 根据上海证券交易所《〈上海证券交易所上市公司自律监管指引第3号一一行业信息披露〉第十四号一 食品制造》 的相关要求，安记食品股份有限公司（以下简称"公司"）现将公司2024年度与行业相关的 定期经营数据披露如下： 一、报告期主营业务相关经营情况 1、 产品类别 单位：万元 币种：人民币 单位：万元 币种：人民币 安记食品股份有限公司董事会 2025年4月22日 证券代码：603696 证券简称：安记食品 公告编号：2025-015 安记食品股份有限公司 关于召开2024年度股东大会的通知 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性承担法律责任 ...

登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码：600873 证券简称：梅花生物 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性承担法律责任。 重要内容提示 公司董事会、监事会及董事、监事、高级管理人员保证季度报告内容的真实、准确、完整，不存在虚假 记载、误导性陈述或重大遗漏，并承担个别和连带的法律责任。 公司负责人、主管会计工作负责人及会计机构负责人（会计主管人员）保证季度报告中财务信息的真 实、准确、完整。 第一季度财务报表是否经审计 □是 √否 一、主要财务数据 (一)主要会计数据和财务指标 单位：元 币种：人民币 ■ (二)非经常性损益项目和金额 单位:元 币种:人民币 ■ 对公司将《公开发行证券的公司信息披露解释性公告第1号一一非经常性损益》未列举的项目认定为非 经常性损益项目且金额重大的，以及将《公开发行证券的公司信息披露解释性公告第1号一一非经常性 损益》中列举的非经常性损益项目界定为经常性损益的项目，应说明原因。 □适用 √不适用 (三)主要会计数据、财务指标发生变动的情况、原因 □适用 □不适用 ■ 二、股东信 ...

股票代码：600305 股票简称：恒顺醋业 公告编号：临 2025-014 江苏恒顺醋业股份有限公司 2024 年年度与行业相关的定期经营数据公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或 者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 根据《上海证券交易所上市公司自律监管指引第3号——行业信息披露第十四号 食品制造》的相关规定，江苏恒顺醋业股份有限公司（以下简称"公司"）现将与行 业相关的定期经营数据披露如下： 一、2024年度主要经营数据 1、按照产品类别分类情况： 3、按照销售渠道分类情况： 单位：万元 | 渠道类型 | 2024 | 年度销售收入 | 2023 年度销售收入 | 同比增减% | | --- | --- | --- | --- | --- | | 线上销售 | | 27,437.81 | 26,471.68 | 3.65 | | 线下销售 | | 181,862.87 | 181,310.50 | 0.30 | | 合计 | | 209,300.68 | 207,782.18 | 0.73 | 4、按照区域分类情况： 单位：万元 单位：万元 ...

2024 年度与行业相关的定期经营数据公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗 漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 证券代码：603696 证券简称：安记食品 公告编号：2025-014 安记食品股份有限公司 | 产品分类 | 2024 | 年度 | 2023 年度 | 同比变动 | | --- | --- | --- | --- | --- | | 国内线下销售 | 18,132.46 | | 20,329.29 | -10.81 | | 国内线上销售 | 2,853.03 | | 3,068.07 | -7.01 | | 国外渠道 | 1,805.23 | | 2,024.49 | -10.83 | | 小计 | 22,790.72 | | 25,421.85 | -10.35 | 3、 地区分布 | 产品分类 | 2024 年度 | 2023 年度 | 同比变动 | | --- | --- | --- | --- | | 华东 | 10,678.45 | 11,126.78 | -4.03 | | 中南 | 9,597.07 | 10,9 ...

证券代码：603057 证券简称：紫燕食品 公告编号：2025-016 上海紫燕食品股份有限公司 2025 年第一季度经营数据公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 根据《上海证券交易所上市公司自律监管指引第3号——行业信息披露》(第 十四号——食品制造)的相关规定，现将上海紫燕食品股份有限公司（以下简称 "公司"）2025 年第一季度主要经营数据（未经审计）公告如下： 一、 公司 2025 年第一季度主要经营情况 1、 主营业务按产品类别分类情况： 单位：元 币种：人民币 分产品 2025 年 1-3 月 金额 占比 鲜货产品 445,982,177.51 80.28% 其中：夫妻肺片 155,830,520.05 28.05% 整禽类 114,007,861.98 20.52% 香辣休闲 48,755,996.49 8.78% 其他鲜货 127,387,798.98 22.93% 预包装及其他产品 80,881,584.49 14.56% 包材 13,669,438.97 2.46% 加盟费、门店管理费、信息 ...

Financial Data and Key Metrics Changes - The company reported record high contributions, recurring profits, and full-year distributions to shareholders, with a total payout of HKD0.25 per share [6][11][12] - The interest coverage ratio at the end of the year was four times, exceeding the comfort level of three times [8][49] - The company maintained two investment-grade credit ratings and had no borrowings due in 2025 [6][7] Business Line Data and Key Metrics Changes - Indofood achieved record revenues for the eleventh consecutive year, with EBIT margins for the Noodles division reaching 25.9%, the highest ever [9][10] - Metro Pacific's core profit also reached record highs, driven primarily by power, water, and toll roads, with expectations for continued strong performance in 2025 [11][12] - PLDT reported record high sales and service revenues, with mobile data and SMS showing the strongest growth [12][14] Market Data and Key Metrics Changes - The company noted that the electricity generation market in Singapore is expected to grow at rates exceeding 4% annually [24] - The Philippines and Indonesia's economies are projected to double from 2018 to 2029, which is expected to positively impact Metro Pacific's revenues and profits [75] Company Strategy and Development Direction - The company is focusing on capitalizing on strong growth in its core businesses, particularly in defensive industries like power and water [75][80] - There are ongoing discussions regarding the potential IPO of Metro Pacific, with a focus on finding new capital through private placements [57][62] - The company is also exploring strategic options for Maya, its fintech venture, including potential IPOs or trade sales in the future [72] Management's Comments on Operating Environment and Future Outlook - Management expressed optimism about the future, indicating that current trends suggest another strong year for Metro Pacific in 2025 and 2026 [75][80] - The management highlighted the importance of improving operational efficiencies and reducing non-revenue water in Metro Pacific's water utility business to enhance valuation [33] Other Important Information - The company has secured long-term contracts for gas supply, which is expected to provide a competitive advantage in the electricity generation market [26] - The new 600 megawatt hydrogen-ready power project is anticipated to begin operations in January 2029, adding significant capacity to the portfolio [16][25] Q&A Session Summary Question: What is the expected earnings trajectory for Pacific Light Power in 2025 and 2026? - Management indicated that 2023 was an exceptional year, and while profits are expected to taper, the overall portfolio remains strong with new projects in the pipeline [24][25] Question: Can you provide updates on the Terra Solar Phase two project? - The focus remains on Phase one of the Terra Solar project, with initial deliveries expected in Q1 2026 [27][29] Question: What are the considerations for the spin-off of MailiNet? - The valuation is tied to strong performance and operational efficiencies, with a focus on reducing non-revenue water [30][33] Question: Will there be share buybacks given the current NAV discount? - Management stated that share buybacks are part of a dynamic capital allocation strategy and will be assessed based on liquidity and other commitments [35][39] Question: What is the financing mix for PLP's new power plant projects? - The financing plan anticipates approximately 60% debt and 40% equity for the project costs [45][47] Question: What are the expected returns for the new power project in Singapore? - Expected returns are projected to be in excess of 12% up to mid-teens for investments in this space [53][54] Question: Any updates on the potential IPO for Maya? - Management confirmed that Maya is at an inflection point with growing customer bases and is generating positive net income, with discussions ongoing about future strategic options [70][72]

Group 1 - The core viewpoint of the announcement is that Shanghai Yuanzu Dream Fruit Co., Ltd. reported a significant decline in total operating revenue for the year 2024 compared to 2023, with a total revenue of 2.22 billion RMB, down 13.25% from 2.56 billion RMB in the previous year [1] Group 2 - Offline sales for 2024 were 838.84 million RMB, a decrease of 34.82% from 1.29 billion RMB in 2023 [1] - Online sales increased by 8.54% to 1.38 billion RMB, accounting for 62.24% of the company's main business revenue [1] - The sales of cakes decreased by 8.35% to 955.20 million RMB, while the sales of Chinese and Western pastries fell by 16.41% to 1.21 billion RMB [1] - The company reported a complete loss of sales in the fruit category, which was previously 9.60 million RMB [1] - Revenue from the mainland region was 2.21 billion RMB, down 13.18% from 2.54 billion RMB in 2023, while revenue from Taiwan decreased by 22.23% to 15.54 million RMB [1]

2、按销售模式分： 证券代码：600873 证券简称：梅花生物 公告编号：2025-027 梅花生物科技集团股份有限公司 关于2024年年度经营数据公告 公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗 漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 根据《上市公司行业信息披露指引第十四号—食品制造》第十四条相关规定， 现将梅花生物科技集团股份有限公司(以下简称"公司")2024 年年度经营数据 公告如下： | 产品类别 | 本期营业收入（万元） | | --- | --- | | 鲜味剂（谷氨酸钠、核苷酸） | 725,445.51 | | 饲料氨基酸（赖氨酸、苏氨酸、饲料级缬氨酸等） | 1,142,352.59 | | 医药氨基酸（谷氨酰胺、脯氨酸、异亮氨酸、鸟苷、腺苷等） | 47,630.86 | | 大原料副产品（肥料、蛋白粉、胚芽、玉米皮粉、饲料纤维等） | 373,933.81 | | 其他（黄原胶、海藻糖等） | 217,566.07 | | 合计 | 2,506,928.83 | 1、按产品分： | 销售模式 | 本期营业收入（万元） | | --- ...

Group 1 - The International Consumer Rights Day activities organized by the State Administration for Market Regulation (SAMR) included over 590 offline events across various regions, with a participation of 123,000 people [1] - The "You Choose, I Test" food safety public opinion collection system has seen 1.458 million participants since its launch on January 2, with consumers primarily concerned about vegetables, meat products, fruits, grains, dairy, condiments, cooking oil, catering food, beverages, and aquatic products [1] - Local market regulation departments have incorporated these food categories into their sampling plans for inspection and monitoring [1] Group 2 - To address population aging and enhance grassroots nutrition guidance, SAMR has collaborated with the China Nutrition Health Food Association to conduct educational lectures on special medical foods at elderly rehabilitation centers [2] - Special medical foods are formulated to meet the nutritional needs of individuals with restricted eating, digestive absorption issues, metabolic disorders, or specific disease states [2] - Personalized special medical food plans are developed based on the health status and nutritional requirements of elderly individuals, combined with rehabilitation training and psychological support [2]